| Dysregulation of brain dopamine systems in major depressive disorder NC Delva, GD Stanwood Experimental Biology and Medicine 246 (9), 1084-1093, 2021 | 41 | 2021 |
| Melanocortin 1 receptor–targeted α-particle therapy for metastatic uveal melanoma NK Tafreshi, CJ Tichacek, DN Pandya, ML Doligalski, MM Budzevich, ... Journal of Nuclear Medicine 60 (8), 1124-1133, 2019 | 40 | 2019 |
| Lipophilicity determines routes of uptake and clearance, and toxicity of an alpha-particle-emitting peptide receptor radiotherapy NK Tafreshi, HJ Kil, DN Pandya, CJ Tichacek, ML Doligalski, ... ACS pharmacology & translational science 4 (2), 953-965, 2021 | 18 | 2021 |
| Tp53 and Hras influence on HPV16 E7 expression in HPV16-transformed human keratinocytes NC Delva | 4 | 2015 |
| Lipophilicity Determines Route of Clearance of a Melanocortin 1 Receptor Targeted Radiopharmaceutical N Tafreshi, HJ Kil, D Pandya, C Tichacek, M Doligalski, M Budzevich, ... Journal of Nuclear Medicine 60 (supplement 1), 546-546, 2019 | 1 | 2019 |
| Stress-related adaptations following loss of dopamine D1 receptors in cerebral cortical interneurons N Delva, D Graham, B Noble, G Stanwood Neurotoxicology and Teratology 98, 107270, 2023 | | 2023 |
| Targeting immune checkpoint therapy to the lung tumor microenvironment AS Cohen, ML Doligalski, H Zheng, NK Tafreshi, V Estrella, N Delva, ... Cancer Research 77 (13_Supplement), 1709-1709, 2017 | | 2017 |
| Targeted alpha particle therapy for uveal melanoma NK Tafreshi, NC Delva, CJ Tichacek, ML Doligalski, DN Pandya, NB Bhatt, ... Cancer Research 77 (13_Supplement), 5198-5198, 2017 | | 2017 |
| Dosimetry of a Novel Targeted Alpha Particle Therapy for Metastatic Uveal Melanoma CJ Tichacek, NK Tafreshi, ML Doligalski, MM Budzevich, E Ruiz, ... MEDICAL PHYSICS 44 (6), 2986-2986, 2017 | | 2017 |
Narges TafreshiCellinfinity BioVerified email at cellinfinitybio.com
